{
    "nctId": "NCT05559528",
    "briefTitle": "BRaziLian outcomE for metAStatic breasT Cancer",
    "officialTitle": "Clinical Outcomes of Breast Cancer and Its Relation With Access to Health Care in Brazil: a Prospective Study in HER2-negative/Hormone Receptor-Positive Metastatic Disease",
    "overallStatus": "RECRUITING",
    "conditions": "Metastatic Breast Cancer, Breast Cancer Stage IV",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "Progression-free survival (PFS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women may be premenopausal or postmenopausal\n* Metastatic advanced breast cancer\n* ER-positive and/or PR-positive, HER2-negative tumor\n* Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, 2 and 3.\n* Start of first-line treatment from 2019\n\nExclusion Criteria:\n\n* Localized or locally advanced disease\n* Lack of information about hormonal receptor and HER2 status\n* Breast cancer in men\n* Breast cancer in pregnancy\n* Have progressed from initiation of first-line treatment to study enrollment",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}